tiprankstipranks
China Health Group Inc. (HK:8225)
:8225
Hong Kong Market
8225
China Health Group Inc.
RESEARCH TOOLSreports

China Health Group Inc. (8225) Ratios

0 Followers

China Health Group Inc. Ratios

HK:8225's free cash flow for Q2 2025 was ¥0.65. For the 2025 fiscal year, HK:8225's free cash flow was decreased by ¥ and operating cash flow was ¥0.47. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 2.17 2.97 3.19 4.82 4.53
Quick Ratio
 2.17 2.97 3.19 4.82 4.53
Cash Ratio
 0.72 0.45 0.12 0.11 0.27
Solvency Ratio
 -0.78 -0.45 -1.64 -0.43 0.86
Operating Cash Flow Ratio
 0.41 0.33 0.03 -0.14 -0.24
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 37.95M¥ 61.39M¥ 77.01M¥ 140.48M¥ 150.24M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.57 1.44 1.41 1.26 1.27
Debt Service Coverage Ratio
 0.00 0.00 0.00 -922.06 2.44K
Interest Coverage Ratio
 0.00 0.00 0.00 -944.53 2.81K
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 0.00 0.00 <0.01 <0.01
Net Debt to EBITDA
 10.50 1.00 0.07 0.26 -0.27
Profitability Margins
Gross Profit Margin
47.33%38.05%38.33%43.87%76.38%
EBIT Margin
-7.98%-56.12%-271.70%-120.77%50.88%
EBITDA Margin
-6.86%-53.83%-270.60%-119.62%51.12%
Operating Profit Margin
-31.31%-56.12%-267.57%-122.67%50.34%
Pretax Profit Margin
-80.25%-54.71%-271.70%-120.90%50.86%
Net Profit Margin
-78.40%-54.88%-270.78%-121.03%43.45%
Continuous Operations Profit Margin
-78.40%-54.88%-271.70%-120.90%43.45%
Net Income Per EBT
97.70%100.32%99.66%100.11%85.43%
EBT Per EBIT
256.27%97.49%101.54%98.56%101.03%
Return on Assets (ROA)
-29.28%-14.38%-48.61%-8.87%18.34%
Return on Equity (ROE)
-35.94%-20.64%-68.40%-11.13%23.35%
Return on Capital Employed (ROCE)
-18.59%-21.29%-68.10%-11.32%27.05%
Return on Invested Capital (ROIC)
-17.28%-21.29%-68.10%-11.32%23.69%
Return on Tangible Assets
-29.28%-14.38%-48.61%-8.87%18.34%
Earnings Yield
-21.91%-7.81%-46.61%-6.22%11.64%
Efficiency Ratios
Receivables Turnover
 0.77 0.46 0.33 0.12 0.64
Payables Turnover
 39.74 33.44 2.38 1.27 2.78
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 14.01 9.70 2.99 9.36 53.94
Asset Turnover
 0.37 0.26 0.18 0.07 0.42
Working Capital Turnover Ratio
 0.60 0.38 0.20 0.09 0.63
Cash Conversion Cycle
 463.66 783.60 961.05 2.75K 438.77
Days of Sales Outstanding
 472.85 794.52 1.11K 3.04K 569.93
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 9.19 10.91 153.09 287.35 131.16
Operating Cycle
 472.85 794.52 1.11K 3.04K 569.93
Cash Flow Ratios
Operating Cash Flow Per Share
 0.01 0.01 <0.01 >-0.01 -0.01
Free Cash Flow Per Share
 0.01 <0.01 >-0.01 >-0.01 -0.01
CapEx Per Share
 <0.01 <0.01 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
 0.93 0.83 -4.36 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 15.04 5.84 0.19 0.00 0.00
Capital Expenditure Coverage Ratio
 15.04 5.84 0.19 0.00 0.00
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.41 0.39 0.05 -0.39 -0.12
Free Cash Flow Yield
10.63%4.59%-3.92%-2.02%-3.29%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.56 -12.80 -2.15 -16.09 8.59
Price-to-Sales (P/S) Ratio
 3.58 7.03 5.81 19.47 3.73
Price-to-Book (P/B) Ratio
 2.10 2.64 1.47 1.79 2.01
Price-to-Free Cash Flow (P/FCF) Ratio
 9.41 21.81 -25.49 -49.43 -30.37
Price-to-Operating Cash Flow Ratio
 8.79 18.07 111.03 -49.43 -30.37
Price-to-Earnings Growth (PEG) Ratio
 -0.05 0.17 >-0.01 0.11 -0.21
Price-to-Fair Value
 2.10 2.64 1.47 1.79 2.01
Enterprise Value Multiple
 -41.58 -12.06 -2.08 -16.02 7.04
Enterprise Value
 92.85M 171.68M 120.32M 250.82M 300.72M
EV to EBITDA
 -41.58 -12.06 -2.08 -16.02 7.04
EV to Sales
 2.85 6.49 5.62 19.16 3.60
EV to Free Cash Flow
 7.51 20.14 -24.64 -48.65 -29.26
EV to Operating Cash Flow
 7.01 16.69 107.33 -48.65 -29.26
Tangible Book Value Per Share
 0.05 0.07 0.08 0.14 0.16
Shareholders’ Equity Per Share
 0.06 0.07 0.09 0.14 0.16
Tax and Other Ratios
Effective Tax Rate
 0.07 >-0.01 0.00 >-0.01 0.15
Revenue Per Share
 0.03 0.03 0.02 0.01 0.08
Net Income Per Share
 -0.03 -0.01 -0.06 -0.02 0.04
Tax Burden
 0.98 1.00 1.00 1.00 0.85
Interest Burden
 10.06 0.97 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.56 0.94 0.36 1.07 0.17
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.02 0.16 <0.01
Income Quality
 -5.92 -0.71 -0.02 0.33 -0.24
Currency in CNY